Shares in German pharmaceutical group Bayer have dropped sharply following a US verdict linking a product to cancer. By mid-morning on Monday, Bayer's shares had lost 10.4% of their value.
A San Francisco jury on Friday ordered agribusiness giant Monsanto to pay US$ 289 million to a former school groundskeeper dying of cancer, saying the company's popular Roundup weed killer contributed to his disease.
Argentina authorized the use of genetically modified soybean seeds resistant to herbicides other than glyphosate, as the European Union (EU) debates whether to extend the license of weed-killers containing the ingredient.
European Union countries failed this week to vote on a license extension for weed-killer glyphosate, delaying again a decision on the widely used herbicide that critics say could cause cancer. The EU said in a statement the relevant committee did not hold a vote at a meeting and that it would announce the date of the next meeting shortly.
Monsanto stepped up its defense of a widely used weed killer by filing a lawsuit in California seeking to prevent glyphosate, the main ingredient in its Roundup herbicide, from being added to the state’s list of known carcinogens.